Abstract
The objective of this study was to investigate the effects of types of dialysis treatments on hepatitis C virus infection and the epidemiologic properties of hepatitis C virus (HCV) infection at three Baskent University hospitals, in Ankara, Adana, and Izmir, Turkey, in 655, 326, and 118 patients with end-stage renal disease, respectively. One hundred thirty patients with HCV viremia among 271 patients with end-stage renal disease seropositive for HCV were included in this cross-sectional study. HCV RNA-positive patients were classified according to the renal replacement therapies (hemodialysis or continuous ambulatory peritoneal dialysis), and viral load, transaminase levels, and distribution of genotypes were compared between these subgroups. In the continuous ambulatory peritoneal dialysis group, 26 of 165 patients (16%) were serum anti-HCV positive, and 11 of 26 patients (42%) were serum HCV RNA positive. Twenty-six percent of the patients undergoing hemodialysis were anti-HCV positive, and 49% were HCV RNA positive. The prevalence of genotype 1b was 68% and 73% for patients in the continuous ambulatory peritoneal dialysis and hemodialysis groups, respectively. No significant differences were found between the genotype 1b and the non-1b groups or between different dialysis types with regard to age and sex and serum aspartate transaminase, alanine aminotransferase, and HCV RNA levels. We conclude that HCV seropositivity may differ between different types of dialysis treatments, although viral load and genotypes may be similar in persons with end-stage renal disease and those without.
Similar content being viewed by others
References
Bukh J, Purcell RH, Miller RH (1992) Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 89:187–191
Martin P, Friedman LS (1995) Chronic viral hepatitis and the management of chronic renal failure. Kidney Int 47:1231–1241
Cendoroglo Neto M, Draibe SA, Silva AE, et al. (1995) Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among hemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 10:240–246
Hinrichsen H, Leimenstoll G, Stegen G, et al. (2002) Prevalence and risk factor of hepatitis C virus infection in hemodialysis patients: a muticentre study in 2796 patients. Gut 51:429–33
Ng YY, Lee SD, Wu SC, et al. (1991) Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med Virol 35:263–266
Fabrizi F, Poordad FF, Martin P (2002) Hepatitis C infection and the patient with end-stage renal disease. Hepatology 36:3–10
Simmonds P, Alberti A, Alter HJ, et al. (1994) A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321–1324
Takada N, Takase S, Takada A, et al. (1993) Differences in the hepatitis C virus genotypes in different countries. J Hepatol 17:277–283
Yoshioka K, Kakumu S, Wakita T, et al. (1992) Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 16:293–299
Chan TM, Lok AS, Cheng IK (1993) Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 17:5–8
World Health Organization (1997) Hepatitis C: global prevalence. Weekly Epidemiol Rec 46:341–348
Simmonds P (1995) Variability of hepatitis C virus. Hepatology 21:570–583
Di Lallo D, Miceli M, Petrosillo N, et al. (1999) Risk factors of hepatitis C virus infection in patients on hemodialysis: a multivariate analysis based on a dialysis register in Central Italy. Eur J Epidemiol 15:11–14
Fabrizi F, Martin P, Dixit V, et al. (1999) Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. Am J Nephrol 19:383–388
de Medina M, Ashby M, Schluter V, et al. (1998) Prevalence of hepatitis C and G virus infection in chronic hemodialysis patients. Am J Kidney Dis 31:224–226
Chen YD, Liu MY, Yu WL, et al. (2002) Hepatitis C virus infections and genotypes in China. Hepatobil Pancreat Dis Int 1:194–201
Ozsoy MF, Oncul O, Cavuslu S, et al. (2003) Seroprevalences of hepatitis B and C among health care workers in Turkey. J Viral Hepat 10:150–156
Gurbuz AK, Doganalp K, Gulsen M (1993) Hepatit C virus infeksiyonunda aile ici gecis. Gastroenteroloji 4:405–408
Hafta A, Çolakoglu S, Akkiz H (1996) Cukurova bölgesinde cesitli risk gruplarinda anti-HCV seroprevalansi. Viral Hepatit Derg 1:46–49
Sayiner AA, Zeytinoglu A, Ozkahya M, et al. (1999) HCV infection in haemodialysis and CAPD patients. Nephrol Dial Transplant 14:256–257
Soetjipto Handajani R, Lusida MI, et al. (1996) Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia. J Clin Microbiol 34:2875–2880
Covic A, Iancu L, Apetrei C, et al. (1999) Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 14:40–45
Picciotto A, Varagona G, Gurreri G, et al. (1993) Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients. Nephrol Dial Transplant 8:1115–1117
Chan TM, Lok AS, Cheng IK (1991) Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 6:944–947
Conwat M, Catteral AP, Brown EA, et al. (1992) Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant 7:1226–1229
Furusyo N, Hayashi J, Kakuda K, et al. (2001) Acute hepatitis C among Japanese hemodialysis patients: a prospective 9-year study. Am J Gastroenterol 96:1592–1600
Fabrizi F, Martin P, Dixit V, et al. (1998) Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay. Am J Kidney Dis 31:647–654
Gilli P, Moretti M, Soffritti S, et al. (1990) Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 13:737–741
Fabrizi F, Martin P, Quan S, et al. (2000) Serotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patients. Am J Kidney Dis 35:832–838
Puttinger H, Vychytil A (2002) Hepatitis B and C in peritoneal dialysis patients. Semin Nephrol 22:351–360
Yalçin K, Degertekin H, Akkiz H (1999) Güneydogu Anadolu’da HCV’na bagli kronik hepatitlerde HCV genotipleri. Turk J Gastroenterol 10(3):249–252
Gorriz JL, Miguel A, Garcia-Ramon R, et al. (1996) Prevalence and risk factors for hepatitis C virus infection in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 11:1109–1112
Weinstein T, Tur-Kaspa R, Chagnac A, et al. (2001) Hepatitis C infection in dialysis patients in Israel. Isr Med Assoc J 3:174–177
Qian KP, Natov SN, Pereira BJ, et al. (2000) Hepatitis C virus mixed genotype infection in patients on haemodialysis. J Viral Hepat 7:153–160
Fabrizi F, Martin P, Dixit V, et al. (2000) Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis 35:122–129
Hung KY, Lee KC, Yen CJ, et al. (1997) Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant 12:180–183
Herrine SK, Michael B, Ma WL, et al. (2002) Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis. Am J Gastroenterol 97:2619–2622
Furusyo N, Hayashi J, Ariyama I, et al. (2000) Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. Am J Gastroenterol 95:490–496
Gonzalez-Michaca L, Soto-Ramirez LE, Rodriguez R, et al. (2001) Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification. Rev Invest Clin 53:21–27
Roudot-Thoraval F, Bastie A, Pawlotsky JM, et al. (1997) Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology 26:485–490
Wiese M, Berr F, Lafrenz M, et al. (2000) Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study. Hepatology 32:91–96
Abacioglu YH, Davidson F, Tuncer S, et al. (1995) The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat 2:297–301
Bozdayi AM, Aslan N, Bozdayi G, et al. (2004) Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Arch Virol 149:2115–2129
Gonzalez-Michaca L, Mercado A, Gamba G (2000) Viral C hepatitis in patients with end-stage renal disease. II. Viral genotypes. Rev Invest Clin 52:491–496
Benani A, El-Turk J, Benjelloun S, et al. (1997) HCV genotypes in Morocco. J Med Virol 52:396–398
Bouchardeau F, Chauveau P, Courouce AM, et al. (1995) Genotype distribution and transmission of hepatitis C virus (HCV) in French haemodialysed patients. Nephrol Dial Transplant 10:2250–2252
Fabrizi F, Lunghi G, Pagliari B, et al. (1997) Molecular epidemiology of hepatitis C virus infection in dialysis patients. Nephron 77:190–196
Zamir D, Storch S, Zonder HB, et al. (1999) Hepatitis C virus seroconversion and genotype prevalence in patients and staff on chronic hemodialysis. J Clin Gastroenterol 28:23–28
Andonov A, Chaudhary RK (1994) Genotyping of Canadian hepatitis C virus isolates by PCR. J Clin Microbiol 32:2031–2034
Abacioglu H (1997) Hepatit C virusunun virolojik ve moleküler özelikleri. Aktüel Tip Dergisi 2:143–150
Perez RM, Ferraz ML, Figueiredo MS, et al. (2003) Unexpected distribution of hepatitis C virus genotypes in patients on hemodialysis and kidney transplant recipients. J Med Virol 69:489–494
Gonzalez-Peralta RP, Qian K, She JY, et al. (1996) Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J Med Virol 49:242–247
Alter MJ, Kruszon-Moran D, Nainan OV, et al. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556–562
Zeuzem S, Franke A, Lee JH, et al. (1996) Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology 24:1003–1009
Beld M, Penning M, McMorrow M, et al. (1998) Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels. J Clin Microbiol 36:872–877
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Selcuk, H., Kanbay, M., Korkmaz, M. et al. Distribution of HCV Genotypes in Patients with End-Stage Renal Disease According to Type of Dialysis Treatment. Dig Dis Sci 51, 1420–1425 (2006). https://doi.org/10.1007/s10620-005-9025-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-9025-9